BioTech Health Policy Medical Billing Meeting 
Health Populi
MAY 19, 2019
This poll from RealClear Politics , conducted in late April/early May 2019, makes my point that the patient is the consumer and, facing deductibles and more financial exposure to footing the medical bill, the payor.
Health Populi
JANUARY 18, 2019
As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.
Expert insights. Personalized for you.
149 
Let's personalize your content